European shares close flat as investors eye Venezuela and economic data
Dublin closes the day down 0.8%
Eli Lilly
Six economic flashpoints to watch out for in 2026
From the US economy to an AI-fuelled bubble, there are pressure points that could yet become global crises
Shares muted as investors digest US jobs data
European defence stocks dip amid hopes for Ukraine peace deal
Eli Lilly’s latest shot helped patients lose 29% of body weight in trials
Trial results are boost to US pharmaceutical company’s booming obesity business
What Taoiseach and Tánaiste told pharma sector amid lobbying efforts on EU reforms
Documents show Government assured the industry that Ireland had its back in Washington and Brussels
Ireland dodged a bullet this year. But there’s a caveat
Trouble for Simon Harris is that GDP figures don’t tend to cheer you up if you are juggling a long commute, childcare costs and soaring grocery bills
Fintan O’Toole: Ireland has two economies, one bourgeois, one proletarian. Both are broken
The bourgeoisification of the Irish workforce is a remarkable phenomenon
Garda probe on insider trading and Government response to AI
The best news, analysis and comment from The Irish Times business desk
Eli Lilly’s trillion-dollar climb exposes Europe’s absence from top ranks of stock markets
US accounts for 72.7% of the MSCI World Index, compared with just 2.6% for Europe’s biggest stock market, France
How a blockbuster weight-loss drug made Ireland the fastest-growing economy in the world
Unprecedented surge in Irish exports this year was almost entirely driven by shipments of drug ingredients for Eli Lilly
Eli Lilly’s blockbuster weight-loss drugs drive surge in Irish exports
Goods sent to US up 150% to €71bn as firms rushed to beat onset of tariffs
Settlement in case of former MD alleged to have taken company info and worked with rival
Dublin-headquartered Laydex Ltd, last month brought proceedings against former MD Gerard Callan
Dublin 6 the most expensive Eircode with house prices at almost €800,000
The best news, analysis and comment from The Irish Times business desk
Eli Lilly’s Dutch move offers Ireland hope
Trump administration pressure on Big Pharma to focus investment on the US has raised concerns in Europe, and specifically the Republic
Former MD agrees not to disclose information allegedly taken from company, court hears
Injunction sought restraining him from using data or disclosing or making it available to others
Trump’s bully boy tactics bringing Big Pharma to heel
Determination to cut prices for medicines in US may yet pile pressure on creaking European health budgets
‘Obesity medications may not make you thin or happy but they will improve your health’
GLP-1 drugs need to be reframed in the public mind as an essential medical treatment rather than ‘skinny jabs’, say practitioners
Big Pharma’s pullback from the UK could have serious side-effects for Ireland
Negotiations on new medicines pricing agreement comes as drug companies are under pressure to relocate investment back to US
Novo versus Lilly spotlights wider Europe-US corporate divide
US firms usually look leaner than their European counterparts when judged by revenue per employee
Project delivery PM Group spots slowdown in FDI wave into Ireland
Irish construction specialist’s fast-growing US business benefiting from reshoring of manufacturing operations under Trump
Weight-loss drugmaker Novo Nordisk to cut 9,000 jobs amid increased competition
The company’s shares have nearly halved since the start of the year and expects slower growth this year
Eli Lilly’s weight-loss breakthroughs face brutal investor scrutiny
Perfection was priced in, anything less provoked panic as shares were hit with worst one-day drop in 25 years
Trump-Putin summit boosts global stocks amid hopes of Ukraine ceasefire
Dublin’s Iseq moves 1% higher as banks and food stocks gain momentum
Eli Lilly obesity pill disappoints in trial, sending shares down 14%
Weight loss comes in at lower end of expectations and triggers stock boost for rival Novo Nordisk
‘A slow-moving car crash’: Novo Nordisk’s troubles keep mounting
Novo Nordisk has now lost two-thirds of its value in little over a year
In Ozempic’s home town they fear two things: a new set of tariffs, and a company in Kinsale
Pharmaceutical giants in Europe brace themselves for a tariffs fight that is likely still to come
Trump says tariffs on pharma and computer chip are likely by August 1st
Additional threat certain to alarm Government already working with EU to reduce impact of threatened 30% general tariff on exports to US
Is Big Pharma’s powerful US lobby shielding Ireland from the worst of Donald Trump’s tariffs?
The best-financed lobbyists in the United States are protecting the pharmaceutical sector, but that may change
Global stocks fluctuate as oil erases rally
Aviation stocks drop amid soaring jet fuel prices in Europe
Ousted Novo Nordisk CEO pays for investors’ inflated hopes
Investor expectations, it seems, are harder to manage than blood sugar
Ireland U-turns to oppose EU pharma reforms after intense lobbying
Pharmaceutical companies stepped up blitz to push Government to back industry position, lobbying logs show
Pharma bosses call for higher drug prices in EU to counter tariff threat
Novartis and Sanofi CEOs push for European benchmark against US prices
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
The GlossOpens in new window
Read the digital edition of The Gloss magazine now
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices